Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study

被引：0

作者：

Nicholas, M. K. ^{[1
,2
,3
,4
]}

Lucas, R. V. ^{[1
,2
,3
,4
]}

Arzbaecher, J. ^{[1
,2
,3
,4
]}

Paleologos, N. ^{[1
,2
,3
,4
]}

Krouwer, H. ^{[1
,2
,3
,4
]}

Malkin, M. ^{[1
,2
,3
,4
]}

Omar, A. ^{[1
,2
,3
,4
]}

Vick, N. A. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] NorthShore Univ Hlth Syst, Evanston, IL USA

[3] Waukesha Mem Hosp, Reg Canc Ctr, Waukesha, WI USA

[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2016

引用

页数：2

共 50 条

[1] Radiotherapy, temozolomide, and bevacizumab followed by irinotecan, temozolomide and bevacizumab in newly diagnosed glioblastoma multiforme: Preliminary results front an ongoing phase II trial
Kirkpatrick, J. P.
Desjardins, A.
Reardon, D. A.
Vredenburgh, J. J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S209 - S209
[2] Bevacizumab in Combination With Radiotherapy and Temozolomide for PatientsWith Newly Diagnosed Glioblastoma Multiforme
van Linde, Myra E.
Verhoeff, Joost J. C.
Richel, Dirk J.
van Furth, Bwouter R.
Reijneveld, Jaap C.
Verheul, Henk M. W.
Stalpers, Lukas J. A.
ONCOLOGIST, 2015, 20 (02): : 107 - 108
[3] UPDATED RESULTS OF PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Lai, Albert
Nghiemphu, Phioanh
Green, Richard M.
Spier, Liz
Peak, Scott
Phuphanich, Surasak
Fehrenbacher, Lou
Kolevska, Tatjana
Polikoff, Jonathan A.
Cloughesy, Timothy F.
NEURO-ONCOLOGY, 2009, 11 (05) : 632 - 632
[4] Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
Urgoiti, Gloria B. Roldan
Singh, Amitabh D.
Easaw, Jacob C.
JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 173 - 177
[5] Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
Gloria B. Roldán Urgoiti
Amitabh D. Singh
Jacob C. Easaw
Journal of Neuro-Oncology, 2012, 108 : 173 - 177
[6] Phase II Study of Bevacizumab in Combination With Temozolomide as Treatment of Patients With Recurrent Glioblastoma Multiforme: Preliminary Analysis of Toxicity
Sepulveda, J.
Belda, C.
Balana, C.
Perez Segura, P.
Reynes, G.
Gil, M.
Gallego, O.
Berrocal, A.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S589 - S589
[7] BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Vredenburgh, James
Desjardins, Annick
Reardon, David
Rich, Jeremy
Kirkpatrick, John
Gururangan, Sridharan
Bailey, Leighann
Friedman, Allan
Bigner, Darell
Friedman, Henry
NEURO-ONCOLOGY, 2008, 10 (05) : 836 - 837
[8] Phase II trial of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme
Lai, A.
Nghiemphu, P.
Green, R.
Spier, L.
Peak, S.
Phuphanich, S.
Fehrenbacher, L.
Kolevska, T.
Polikoff, J.
Cloughesy, T.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[9] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Kortmann, Rolf-Dieter
STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 670 - 671
[10] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Lai, Albert
Tran, Anh
Nghiemphu, Phioanh L.
Pope, Whitney B.
Solis, Orestes E.
Selch, Michael
Filka, Emese
Yong, William H.
Mischel, Paul S.
Liau, Linda M.
Phuphanich, Surasak
Black, Keith
Peak, Scott
Green, Richard M.
Spier, Cynthia E.
Kolevska, Tatjana
Polikoff, Jonathan
Fehrenbacher, Louis
Elashoff, Robert
Cloughesy, Timothy
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148

← 1 2 3 4 5 →